The use of TXA (OR, 0.39; 95% CI, 0.34–0.45; p < 0.001) was an independent predictor for significant hemorrhage i.e., when TXA was used, the risk of an Hb drop > 20 g/L was 0.39 times lower. The gene discussed is GSTM1; the disease is hemorrhage.